Morningstar

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Provided by Business Wire

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Edwards Lifesciences (NYSE: EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting will include a live Q&A session with physicians and members of the Edwards management team.

A live webcast of the event will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Media Contact: Eric Endicott, media@edwards.com
Investor Contact: Gerianne Sarte, investor_relations@edwards.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20261005711365/en/

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments

Ask the Analyst columnist Amy Arnott answers a grab bag of reader questions about bond ETFs, TIPS, retirement planning, and more.
Amy C. Arnott, CFA and Ivanna Hampton

Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner

With a 3.3% dividend yield and earnings growth expected to exceed management’s outlook, this 4-star stock stands out in a struggling sector.
Andrew Bischof, CFA, CPA

3 Stocks to Sell and 3 Stocks to Buy for October

Plus, lessons from September’s stock market activity.
David Sekera, CFA and Susan Dziubinski

The Thrilling 37

Just a few strict screens can narrow the field to an elite group of funds.
Russel Kinnel

The 10 Best and 10 Worst Months of All Time for the US Stock Market

Do common investor sayings about particular months being stronger or weaker for stocks have empirical backing, or is it all market mythology? Dan Lefkovitz uncovered some surprising truths about stock market performance by examining over 100 years of data.
Dan Lefkovitz

Sponsor Center